Literature DB >> 21501296

Pathological spectrum of intrahepatic cholangiocarcinoma arising in non-biliary chronic advanced liver diseases.

Yasuni Nakanuma1, Jing Xu, Kenichi Harada, Yasunori Sato, Motoko Sasaki, Hiroko Ikeda, Jihun Kim, Eunsil Yu.   

Abstract

Intrahepatic cholangiocarcinoma (ICC) is reported to develop in non-biliary chronic advanced liver diseases (CALD). Herein, we characterize the pathological features of ICC arising in CALD in comparison with those in non-CALD livers. Of 471 surgically resected cases of ICC in Kanazawa, Japan and Seoul, Korea, 53 were associated with CALD (group A), while the remaining 418 arose in otherwise normal livers (group B). When ICC were classified into bile duct type, bile ductular type, variants, and intraductal papillary neoplasm of the bile duct (IPNB), the whole spectrum of subtypes were found in group A; the majority of ICC belonged to the bile duct type in both groups. In group A, bile ductular type was rather frequent (22.6%) compared with group B (8.4%). IPNB was more frequent in group B (22.5%) than group A (3.8%), and in group B, frequent in Seoul cases (24.8%), but rare in Kanazawa cases (2.3%). Variants of ICC were rare in both groups. These results imply that cholangiocarcinogenesis itself is upregulated in group A in comparison with group B and that the bile ductular type is specifically related to group A. Some unique environmental factors in Seoul may be responsible for the frequent development of IPNB.
© 2011 The Authors. Pathology International © 2011 Japanese Society of Pathology and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21501296     DOI: 10.1111/j.1440-1827.2011.02665.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  11 in total

Review 1.  Biphenotypic (hepatobiliary) primary liver carcinomas: the work in progress.

Authors:  Elizabeth M Brunt; Valerie Paradis; Christine Sempoux; Neil D Theise
Journal:  Hepat Oncol       Date:  2015-07-28

Review 2.  Cholangiocarcinoma and malignant bile duct obstruction: A review of last decades advances in therapeutic endoscopy.

Authors:  Helga Bertani; Marzio Frazzoni; Santi Mangiafico; Angelo Caruso; Mauro Manno; Vincenzo Giorgio Mirante; Flavia Pigò; Carmelo Barbera; Raffaele Manta; Rita Conigliaro
Journal:  World J Gastrointest Endosc       Date:  2015-06-10

3.  Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).

Authors:  Jesus M Banales; Vincenzo Cardinale; Guido Carpino; Marco Marzioni; Jesper B Andersen; Pietro Invernizzi; Guro E Lind; Trine Folseraas; Stuart J Forbes; Laura Fouassier; Andreas Geier; Diego F Calvisi; Joachim C Mertens; Michael Trauner; Antonio Benedetti; Luca Maroni; Javier Vaquero; Rocio I R Macias; Chiara Raggi; Maria J Perugorria; Eugenio Gaudio; Kirsten M Boberg; Jose J G Marin; Domenico Alvaro
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-04-20       Impact factor: 46.802

Review 4.  Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.

Authors:  Kelly J Lafaro; David Cosgrove; Jean-Francois H Geschwind; Ihab Kamel; Joseph M Herman; Timothy M Pawlik
Journal:  Gastroenterol Res Pract       Date:  2015-05-19       Impact factor: 2.260

Review 5.  Cholangiocarcinoma as an Indication for Liver Transplantation in the Era of Transplant Oncology.

Authors:  Enrico Gringeri; Martina Gambato; Gonzalo Sapisochin; Tommy Ivanics; Erica Nicola Lynch; Claudia Mescoli; Patrizia Burra; Umberto Cillo; Francesco Paolo Russo
Journal:  J Clin Med       Date:  2020-05-05       Impact factor: 4.241

6.  Epidermal growth factor-like domain multiple 7 (EGFL7): Expression and possible effect on biliary epithelium growth in cholangiocarcinoma.

Authors:  Caterina L Mammola; Antonella Vetuschi; Luigi Pannarale; Roberta Sferra; Romina Mancinelli
Journal:  Eur J Histochem       Date:  2018-11-30       Impact factor: 3.188

Review 7.  Fibroinflammatory Liver Injuries as Preneoplastic Condition in Cholangiopathies.

Authors:  Stefania Cannito; Chiara Milani; Andrea Cappon; Maurizio Parola; Mario Strazzabosco; Massimiliano Cadamuro
Journal:  Int J Mol Sci       Date:  2018-12-04       Impact factor: 5.923

Review 8.  Liquid biopsy in cholangiocarcinoma: Current status and future perspectives.

Authors:  Gianluca Rompianesi; Marcello Di Martino; Alex Gordon-Weeks; Roberto Montalti; Roberto Troisi
Journal:  World J Gastrointest Oncol       Date:  2021-05-15

Review 9.  New insights into cholangiocarcinoma: multiple stems and related cell lineages of origin.

Authors:  Maria Consiglia Bragazzi; Lorenzo Ridola; Samira Safarikia; Sabina Di Matteo; Daniele Costantini; Lorenzo Nevi; Vincenzo Cardinale
Journal:  Ann Gastroenterol       Date:  2017-11-02

10.  Resected primary mucinous cholangiocarcinoma of the liver.

Authors:  Kei Hagiwara; Kenichiro Araki; Takahiro Yamanaka; Norihiro Ishii; Takamichi Igarashi; Akira Watanabe; Norio Kubo; Norifumi Harimoto; Hiroyuki Kuwano; Sumito Nobusawa; Shinichi Aishima; Ken Shirabe
Journal:  Surg Case Rep       Date:  2018-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.